VanEck Biotech ETF (NASDAQ:BBH) Sees Significant Decrease in Short Interest

VanEck Biotech ETF (NASDAQ:BBH) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 2,200 shares, a decrease of 24.1% from the January 31st total of 2,900 shares. Based on an average trading volume of 11,700 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Tyler Stone Wealth Management increased its holdings in shares of VanEck Biotech ETF by 79.5% during the third quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock valued at $261,000 after acquiring an additional 652 shares in the last quarter. Coastline Trust Co acquired a new stake in VanEck Biotech ETF in the 3rd quarter valued at $59,000. Truvestments Capital LLC bought a new stake in VanEck Biotech ETF during the 3rd quarter valued at $44,000. FSA Wealth Management LLC acquired a new position in VanEck Biotech ETF during the third quarter worth $54,000. Finally, Kovitz Investment Group Partners LLC lifted its stake in shares of VanEck Biotech ETF by 4.6% in the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock valued at $565,000 after buying an additional 141 shares in the last quarter. 32.05% of the stock is owned by institutional investors and hedge funds.

VanEck Biotech ETF Trading Down 1.2 %

NASDAQ:BBH opened at $162.53 on Tuesday. VanEck Biotech ETF has a 12 month low of $151.35 and a 12 month high of $183.64. The stock has a market capitalization of $390.07 million, a price-to-earnings ratio of 30.97 and a beta of 0.77. The firm has a fifty day simple moving average of $161.60 and a two-hundred day simple moving average of $168.93.

VanEck Biotech ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Tuesday, December 24th. Investors of record on Monday, December 23rd were given a $1.2517 dividend. The ex-dividend date of this dividend was Monday, December 23rd.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.